NEW YORK / RankWire.AI / – U.S. stocks experienced modest increases on Wednesday, primarily driven by a sharp decline in long-term Treasury yields. The S&P 500 climbed 16.22 points, or 0.21%, reaching 7,707.98 and ending a streak of three consecutive losing sessions. The Dow Jones Industrial Average gained 119.65 points, or 0.22%, closing at 53,463.05. Meanwhile, the Nasdaq Composite rose by 41.38 points, or 0.16%, finishing at 26,331.09. The downward movement in government bond yields helped the major indices recover after several sessions marked by pressure from rising borrowing costs.
Bond prices increased following the U.S. Treasury Department‘s announcement of expanded liquidity support buybacks for longer-term government debt. Effective September 9, the cap for purchases will rise from $2 billion to at least $4 billion per transaction. This adjustment applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity ranges. The increased buyback volumes will remain in place through November 4. The department indicated that robust demand for high-quality offers prompted this decision to boost liquidity operations in these sectors.
Following the announcement, Treasury yields moved lower, reversing some of the recent upward trend in long-term borrowing costs. The 10-year Treasury yield fell to approximately 4.65%, and the 30-year yield declined to around 5.20%. The 30-year yield had hit 5.337% on Tuesday, its highest point since 2007. Since bond yields move inversely to prices, the increased demand for government debt pushed yields down, easing the pressure that had built up during the recent selloff in longer-duration bonds.
Healthcare Stocks Boost Market Performance
Healthcare equities contributed to the day’s gains, with several pharmaceutical firms posting significant increases. Moderna shares soared by 177%, and Merck gained 12.6% after both companies reported positive outcomes from a Phase 3 melanoma trial. The INTerpath-001 trial evaluated the personalized mRNA therapy intismeran autogene in combination with Keytruda following surgical removal of high-risk melanoma. The trial met its primary endpoint for recurrence-free survival and also achieved a key secondary endpoint measuring survival without distant cancer spread.
This healthcare rally helped offset mixed results elsewhere, especially within the technology sector. Consumer stocks also contributed, buoyed by several companies releasing quarterly earnings during the session. Estée Lauder advanced over 16% following its earnings report, adding to gains among consumer-focused shares. Target and Lowe’s also saw upward movement after releasing their latest financial results. Smaller-cap stocks generally outperformed the major indexes, with the Russell 2000 rising about 0.5% as the broader market regained footing.
Indexes End Three-Day Losing Streak
The gains on Wednesday marked the end of a three-session losing streak for the S&P 500, Dow, and Nasdaq. The rebound followed earlier declines driven by rising long-term yields. Despite the positive session, the major indexes still closed the week lower than the previous Friday. The S&P 500 was about 1% below its level at the end of last week, the Dow had dropped roughly 0.5%, and the Nasdaq was approximately 1.5% lower.
However, the broader year-to-date outlook remains positive despite the weekly dip and recent bond market pressures. As of Wednesday’s close, the S&P 500 has gained about 12.6% since the start of the year, with the Dow increasing roughly 11.2%. The Nasdaq continues to lead with a year-to-date gain of approximately 13.3%, reflecting its stronger overall performance. Wednesday’s market movement represented a modest recovery for Wall Street, supported by lower Treasury yields and gains in healthcare stocks that lifted all three major U.S. stock indexes.